Concepedia

Ron Cohen

RC

Statistics

Publications

15

Citations

1.8K

H-Index

14

Active since

1972

Affiliations

Acorda Therapeutics (United States)(Current)

Evergreen Health Medical Center

University of Rochester Medical Center

Cleveland Clinic

University of Rochester

Ron Cohen is an author at Acorda Therapeutics (United States) specializing in clinical pharmacology, pharmacotherapy, and medicine.

ORCID

Publications per year

1972–2015

15

Publications

15

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

Andrew Goodman, Theodore R. Brown, Lauren Krupp et al. · The Lancet · 2009 · 549 citations

, , +8

A phase 3 trial of extended release oral dalfampridine in multiple sclerosis

Andrew Goodman, Theodore R. Brown, Keith R. Edwards et al. · Annals of Neurology · 2010 · 373 citations

, , +12

Dose comparison trial of sustained-release fampridine in multiple sclerosis

Andrew Goodman, Ted R. Brown, J. A. Cohen et al. · Neurology · 2008 · 178 citations

, , +16

Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study

Andrew Goodman, Jeffrey A. Cohen, Anne H. Cross et al. · Multiple Sclerosis Journal · 2007 · 151 citations

, , +14

CRISPR germline engineering—the community speaks

Katrine Bosley, Michael Botchan, Annelien L. Bredenoord et al. · Nature Biotechnology · 2015 · 143 citations · Full text

, , +10

1–5 of 15